BSN-AS1

Across TCGA pan-cancer cohorts, BSN-AS1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of BSN-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where BSN-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BSN-AS1 is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

BLCA and PRAD are the cancer types where BSN-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BSN-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.058	.049	2	view →
PRAD	All	All	−0.022	.047	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

BSN-AS1–BLCA

Open the BLCA breakdown →